An ancient aquatic species that's been around for 450 million years is facing extinction as a series of factors work against the longevity of the living fossil.
Median radiographic progression free survival ('rPFS”) was 15.7 months and the six-month rPFS rate ('rPFS6”) was 82.2% in patients who received prior abiraterone ...
The zoldonrasib combination produced a 54% response rate in 35 evaluable pancreatic cancer patients. Tango expects to start a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results